Actinium Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.836; its P/E ratio is -3.95; Actinium Pharmaceuticals is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 81.00K	-	-	-	-
Gross Profit	$ 81.00K	-	-	-	-
EBIT	$ -10.42M	$ -14.35M	$ -15.64M	$ 12.13M	$ -11.29M
EBITDA	$ -10.22M	$ -14.15M	$ -15.43M	$ 12.31M	$ -11.13M
Net Income Common Stockholders	$ -9.32M	$ -13.28M	$ -15.18M	$ 12.13M	$ -10.65M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 76.68M	$ 82.98M	$ 91.28M	$ 94.92M	$ 109.31M
Total Assets	$ 81.44M	$ 88.94M	$ 99.05M	$ 101.40M	$ 113.59M
Total Debt	$ 10.07M	$ 10.36M	$ 9.15M	$ 7.86M	$ 10.63M
Net Debt	$ -66.61M	$ -72.62M	$ -82.13M	$ -87.06M	$ -98.68M
Total Liabilities	$ 45.07M	$ 45.36M	$ 45.97M	$ 44.82M	$ 47.71M
Stockholders Equity	$ 36.38M	$ 43.58M	$ 53.08M	$ 57.21M	$ 66.48M
Cash Flow	-
Free Cash Flow	$ -7.49M	$ -11.15M	$ -13.69M	$ -15.15M	$ -7.79M
Operating Cash Flow	$ -7.49M	$ -11.13M	$ -13.64M	$ -15.08M	$ -7.78M
Investing Cash Flow	-	$ -30.00K	$ -47.00K	$ -76.00K	$ -16.00K
Financing Cash Flow	$ 1.19M	$ 2.86M	$ 10.05M	$ 770.00K	$ 4.89M

Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

Income Statement >

Actinium Pharmaceuticals Debt to Assets

Balance Sheet >

Actinium Pharmaceuticals Cash Flow

Cash Flow >

Actinium Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing